GDTC Earnings
CytoMed Therapeutics Limited
1W: -7.8%
1M: +0.0%
3M: -9.3%
YTD: -36.7%
1Y: -56.2%
3Y: -74.2%
$0.92
+0.02 (+2.23%)
Weekly Expected Move ±12.4%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2025-09-30
EPS
$-0.07
▼ Miss +0.0%
Revenue
$106K
▲ Beat +0.0%
Next Earnings
2026-11-13
Revenue Estimate
$127K
Estimate vs Actual
Earnings Surprise History
0/16
EPS Beats
0/16
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | quarter | 2026-09-30 | $— | $— | — | $184,343 | $162,646 |
| 2026-09-16 | quarter | 2026-09-30 | $— | $— | — | $— | $184,343 |
| 2026-08-11 | annual | 2023-12-31 | $-0.26 | $-0.34 | ▼ 0.08 | $520,000 | $688,102 |
| 2026-08-11 | quarter | 2024-03-31 | $— | $-0.04 | ▼ 0.04 | $— | $210,961 |
| 2026-06-29 | annual | 2025-12-31 | $-0.17 | $-0.22 | ▼ 0.05 | $520,000 | $668,569 |
| 2026-06-29 | annual | 2024-12-31 | $-0.15 | $-0.20 | ▼ 0.05 | $571,000 | $779,649 |
| 2026-06-29 | quarter | 2025-06-30 | $-0.04 | $-0.05 | ▼ 0.01 | $130,000 | $165,900 |
| 2026-06-29 | quarter | 2025-03-31 | $-0.04 | $-0.05 | ▼ 0.01 | $130,000 | $175,063 |
| 2026-06-29 | quarter | 2024-06-30 | $-0.03 | $-0.04 | ▼ 0.01 | $156,000 | $211,426 |
| 2026-04-09 | quarter | 2025-03-31 | $— | $-0.04 | ▼ 0.04 | $— | $130,000 |
Earnings Call Transcripts
No transcripts available.